Strategi Rumah Sakit di Indonesia dalam Mengatasi Kenaikan Kasus COVID-19 Varian Omicron : Literature Review
Hospital Strategy in Indonesia in Overcoming the Rise in Omicron Variants of COVID-19 Cases : Literature Review
Abstract
Latar Belakang: Corona Virus Disease-19 (COVID-19) khususnya varian Omicron menyebar dengan sangat cepat hingga menjadi penyakit pandemi yang menyebabkan peningkatan angka kematian selama satu tahun terakhir. Di Indonesia yang padat penduduknya, rumah sakit rujukan dituntut dapat mengatasi lonjakan kasus COVID-19 varian Omicron. Tidak hanya itu, lonjakan kasus COVID-19 varian Omicron juga mempengaruhi angka penularan pada tenaga kesehatan di rumah sakit rujukan.
Tujuan: Tujuan dari penulisan artikel ini adalah untuk secara sistematis mengkaji mengenai strategi rumah sakit rujukan dalam menangani lonjakan kasus COVID-19 varian Omicron, sehingga dapat berguna dalam penerapannya untuk meningkatkan efektivitas pelayanan pasien COVID-19 dan pasien lainnya, serta dapat menurunkan angka penularan dan kematian di rumah sakit.
Metode: Kajian ini menggunakan database: PubMed dan Google Scholar. Penyusunan dan evaluasi judul abstrak dilakukan dengan menggunakan Mendeley, begitu juga dengan identifikasi dan menghapus abstrak yang ganda.
Hasil: Hasil kajian dari tiga artikel yang terpilih mencakup masalah yang didapatkan rumah sakit rujukan selama lonjakan COVID-19 varian Omicron dan strateginya dalam menangani masalah-masalah tersebut. Masalah yang didapatkan adalah ketidakseimbangan antara kebutuhan dan keterbatasan sarana dan prasarana kesehatan akibat lonjakan, serta ditemukannya angka penularan di rumah sakit rujukan. Dari masalah-masalah tersebut, rumah sakit rujukan melakukan penyusunan strategi berupa pembentukan tim khusus yang menangani lonjakan COVID-19 varian Omicron, menetapkan strategi 3T untuk staf rumah sakit rujukan, dan menetapkan strategi teknologi telemedicine.
Kesimpulan: Dalam menangani lonjakan COVID-19 varian Omicron, rumah sakit rujukan perlu menetapkan strategi untuk memaksimalkan pelayanan kesehatan dan memutus rantai penularan COVID-19 varian Omicron.
References
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomedica. 2020;91(1):157-160. doi:10.23750/abm.v91i1.9397.
WHO. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. 2021. Diakses tanggal 26 Desember 2021.
Silalahi FES, Hidayat F, Dewi RS, Purwono N, Oktaviani N. GIS-based approaches on the accessibility of referral hospital using network analysis and the spatial distribution model of the spreading case of COVID-19 in Jakarta, Indonesia. BMC Health Services Research. 2020;20(1):1-20. doi:10.1186/s12913-020-05896-x
Hidayat R, Aini N, Ilmi AFN, Azzahroh F, Giantini A. Test, Trace, and Treatment Strategy to Control COVID-19 Infection Among Hospital Staff in a COVID-19 Referral Hospital in Indonesia. Acta medica Indonesiana. 2020;52(3):206-213
Carenzo L, Costantini E, Greco M, et al. Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020;75(7):928-934. doi:10.1111/anae.15072
Carenzo L, Costantini E, Greco M, et al. Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020;75(7):928-934. doi:10.1111/anae.15072
Li P, Liu X, Mason E, et al. How telemedicine integrated into China’s anti-COVID-19 strategies: case from a National Referral Center. BMJ health & care informatics. 2020;27(3):1-4. doi:10.1136/bmjhci-2020-100164
Walker PGT, Whittaker C, Watson OJ, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- And middle-income countries. Science. 2020;369(6502):413-422. doi:10.1126/science.abc0035
Park Y, Huh IS, Lee J, et al. Application of Testing-Tracing-Treatment Strategy in Response to the COVID-19 Outbreak in Seoul, Korea. Journal of Korean medical science. 2020;35(45):e396. doi:10.3346/jkms.2020.35.e396
Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. New England Journal of Medicine. 2020;382(18):1679-1681. doi:10.1056/nejmp2003539
Wang T-T, Li J-M, Zhu C-R, et al. Assessment of Utilization and CostEffectiveness of Telemedicine Program
in Western Regions of China: A 12-Year Study of 249 Hospitals Across 112 Cities. Telemedicine and e-Health. 2016;22(11):909-920. doi:10.1089/tmj.2015.0213
Song X, Liu X, Wang C. The role of telemedicine during the COVID-19 epidemic in China - Experience from Shandong province. Critical Care. 2020;24(1):178. doi:10.1186/s13054-020-02884-9
Hong Z, Li N, Li D, et al. Telemedicine during the COVID-19 pandemic: Experiences from Western China. Journal of Medical Internet Research. 2020;22(5):e19577. doi:10.2196/19577
WuZ, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. Epub ahead of print.
Liu Y, Li J, Feng Y. Critical care response to a hospital outbreak of the 1325 2019-nCoV infection in Shenzhen, China. Crit Care. 2020;24(1):56.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
